Organogenesis Completes Rolling BLA Submission To FDA For ReNu, Cryopreserved, Amniotic Suspension Allograft Developed For Management Of Symptomatic Knee Osteoarthritis

Benzinga Newsdesk www.benzinga.com Positive 66.4%

Neg 0% Neu 0% Pos 66.4%

Comments

No comments yet. Be the first!